Impacts of COVID-19 on Global Healthcare Management and Research by Autore, Stephanie & De, Santanu
Nova Southeastern University 
NSUWorks 
Biology Faculty Articles Department of Biological Sciences 
1-2022 




Follow this and additional works at: https://nsuworks.nova.edu/cnso_bio_facarticles 
 Part of the Biology Commons, and the Medicine and Health Sciences Commons 
 
Advanced Journal of Graduate Research 
ISSN:2456-7108 
Volume 11, Issue 1, pp. 52-60, January 2022 
DOI: https://doi.org/10.21467/ajgr.11.1.52-60 
 
   
 
Copyright © 2021. The Author(s). Published by AIJR Publisher. 
This is an open access article under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, 
which permits any non-commercial use, distribution, adaptation, and reproduction in any medium, as long as the original work is 
properly cited. 
GRADUATE  RE VIE W ARTICLE  
Impacts of COVID-19 on Global Healthcare Management and 
Research 
Stephanie Autore, Santanu De 
Department of Biological Sciences, Halmos College of Arts and Sciences, Nova Southeastern University,  
3301 College Avenue, Fort Lauderdale, Florida 33314, U.S.A. 
1 Introduction 
On March 11, 2020, the World Health Organization (WHO) declared the Coronavirus Infectious Disease 
2019 (COVID-19) to be a pandemic, affecting multiple countries worldwide, and infecting millions of 
individuals [1]. The novel strain of this family of viruses, Severe Acute Respiratory Syndrome Coronavirus 
2 (SARS-CoV-2), originated in late 2019 within Wuhan, China, with a spread that rapidly developed and 
disproportionately infected those over 40 years of age [2]. Individuals with comorbid conditions, such as 
cancer and cardiovascular disease, are especially at risk of infection and have an increased chance of 
A B S T R A CT  
The Coronavirus Infectious Disease 2019 (COVID-19) pandemic has 
affected most nations at all levels of functioning, individual to 
governmental. Therefore, it is imperative to evaluate the effects the virus 
has had on one of the most important socioeconomic global sectors, 
healthcare. This literature review explores key, recent research and 
management strategies that have been undertaken in healthcare systems 
around the world in order to make meaningful attempts at identifying the 
etiology, diagnosis, and treatment of the disease, and combating the spread 
of this deadly virus. Healthcare facilities have implemented a variety of 
changes, all geared towards reducing non-emergency patient visits and 
preventing transmission of the infection; this includes shifting 
appointments to online modality via telecommunication use, altering 
remedial options and procedures, and developing more effective personal 
protective equipment (PPE). Efforts have also been made to define 
appropriate treatment methods as well as a potential cure for COVID-19; 
many vaccines and antiviral drugs have been designed or are continuing 
to undergo clinical testing, and symptom management approaches are 
being employed along with careful evaluation or recommendation of 
already available medications to counter the disease. Our comprehensive 
analysis provides insights into prominent consequences as well as 
implications of COVID-19 in contemporary global healthcare research 
and management, and would help this crucial sector be better prepared 
for pandemics in the future.   
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mortality due to a weakened immune system [3-5]. The origin of this coronavirus is still relatively unknown; 
however, there has been speculation that it may have originated from the preparation of bats in a seafood 
market of Wuhan, China, or the manipulation of another coronavirus within a laboratory [2]. Nonetheless, 
recent studies have isolated SARS-CoV-2 as the main strain causing the disease, containing an angiotensin-
converting enzyme-2 (ACE-2) binding domain, which binds the ACE-2 receptor in various vital organs 
throughout the body [2]. The wide disbursement of the ACE-2 receptor within the human body may cause 
infection of COVID-19 to provide a wide variety of symptoms in some patients, making the illness even 
more complex to treat and manage. The predominant means of transmission of the coronavirus is 
production of respiratory droplets, which may land on nearby surfaces or travel through the air and be 
inhaled by another individual [2]. The incubation period of this virus is relatively long, spanning anywhere 
between 2-14 days prior to symptom development; thus, an individual may be unknowingly infected and 
could pass on the virus to others quite easily [2].  
The COVID-19 outbreak has impacted various areas of research and management of healthcare throughout 
the globe. Federal and state governments of numerous countries have ordered frequent lockdowns, forcing 
the workforce to move operations online, and instilling new terms, such as “social distancing” to assist in 
controlling the contagion. In the realm of healthcare, new research methodologies and management 
practices have been quickly underway to develop effective treatment options and a possible cure for 
COVID-19. Preventative protocols have been put in place within healthcare facilities to inhibit the spread 
of the virus and lessen the risk of transmission among people or communities. The occurrence of COVID-
19 has transformed many fields of medicine and continues to manifest before the eyes of the world. The 
newness of the disease, and its constantly evolving status due to repeated mutations of the virus, have 
rendered it as one of the most influential topics of worldwide concern in recent times. The purpose of this 
literature review is to highlight recently published, notable reports on the effects of COVID-19 on 
multifarious aspects of healthcare research and management across the world. 
2 Efforts of Global Healthcare Research and Management 
2.1 Patient Care Management  
COVID-19 has posed serious risks to healthcare workers and patients in the healthcare setting, especially 
those who are immunocompromised or require urgent care. This has caused healthcare facilities around the 
world to make significant changes in ways of providing healthcare efficiently and effectively. Among the 
initial changes made by healthcare systems following the pandemic’s onset was the cancellation of elective 
surgeries and the implementation of telecommunication for physician appointments [6, 7]. Such processes 
have been applied in healthcare facilities across Norway, Sweden, the United States, Australia, England, and 
Egypt. These efforts allow for the reduction in volume of patients within the hospital, reducing possible 
transmission of the virus, while permitting vital resources to be allocated to patients who are severely ill, 
whether suffering from COVID-19 or other ailments [6]. Remote monitoring of patient conditions is now 
being widely utilized; in England, for example, a smartphone app (TeleCheck-AF) is being applied on 
cardiac patients who may experience atrial fibrillation [8]. The application uses smartphone technology to 
check the patient’s pulse and evaluate any changes for signs of atrial fibrillation; this information is 
consistently synced with physician charts for examination, enabling continuous remote monitoring of the 
patient’s health [8]. Cardiac patients in England now also have the opportunity to complete rehabilitation 
programs from home; projects such as “Activate Your Heart”, which offer home exercise programs for 
cardiac patients, are now being offered on video-chat software and have even seen an increase in usage by 
patients since the start of the pandemic [8]. 
For individuals who must receive in-patient care due to a severe condition, hospitals and other healthcare 
facilities have been enforcing strict guidelines within the system to hinder distribution of the virus. Such 
regulations include the mandate of wearing facial coverings within the hospital setting, restricting, or 
reducing visitors from entering clinics, and testing for COVID-19 prior to surgery and other procedures [3, 
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5]. Some immunocompromised patients who are receiving ongoing treatment, such as chemotherapy for 
cancer, may have their treatment schedules altered to mitigate the need for in-person visits; however, this 
depends on the stage and rate of growth of the condition [4, 5]. Egypt has also taken steps to establish 
separate hospitals focused on treating COVID-19 patients only; this would assist in preventing cross-
contamination between hospital departments [3, 9]. Patients are placed in the COVID-19 hospital after 
being tested for the virus through COVID-19 screening procedures; if a patient tests positive for COVID-
19, he or she must immediately be transferred to the designated COVID-19 hospital for treatment, while a 
negative result would allow the patient to be placed in a temporary holding ward until retesting and further 
placement into the appropriate department are carried out [3].   
Social-distancing measures have been established within hospital waiting rooms, with seats placed six feet 
apart from one another on all sides [3]. Singapore has also taken a special initiative into consideration to 
develop strategies that limit the spread of the virus in the healthcare setting: the Systems Engineering 
Initiative for Patient Safety (SEIPS), which provides a holistic view of healthcare – visualizing how each 
healthcare worker interacts with the environment and associated technologies [9]. With recommendations 
from SEIPS, Singapore has implemented body temperature checks twice daily for healthcare workers, with 
the temperature not to exceed 37.5℃ [9]. Additionally, the use of negative pressure patient-care rooms has 
been established to prevent air contamination between rooms and other facilities [9].   
Many healthcare services have been modifying the way certain medical procedures are performed to prevent 
aerosolization of respiratory particles; procedures that increase the risk of aerosolization include intubation, 
extubation, and manual ventilation procedures [10]. However, in some nations, such as the United 
Kingdom, these procedures may not be recognized as providing an increased risk of transmission, likely 
increasing the chances of spread of the virus to others [10]. In oncology departments within the United 
States, procedures that screen for cancer are being modified from endoscopies and bronchoscopies to 
Computed Tomography (CT)-guided biopsies to reduce the production of respiratory droplets [4]. If high-
risk aerosolization procedures cannot be avoided, then stringent precautions are taken; for example, in the 
cardiology departments within Egypt, intubation procedures are completed prior to entrance into the 
operating room, ensuring that all nonessential personnel exit the room first [3]. With these efforts, the 
hospital departments are ensuring that COVID-19 is under control within the realm of healthcare as much 
as possible. 
2.2 Personal Protective Equipment (PPE) 
The high transmissibility of COVID-19 has caused a rapid increase in the need for the manufacture and 
use of appropriate personal protective equipment (PPE) to protect healthcare workers. COVID-19 spreads 
primarily through respiratory droplets, which can travel through the air or land on surfaces prior to being 
consumed or inhaled by another individual [2]. The length of time that the virus may survive on a surface 
depends on the material, whether porous or solid; however, this range can vary between a few hours to 
several days [2, 11]. Research conducted in the United Kingdom has recognized aerosolized droplets as 
carrying a significant viral load and posing the highest risk to healthcare staff [10]. Thus, studies have been 
conducted all over the world to develop proper PPE that will protect the health of frontline workers during 
this unprecedented time. Such PPE includes the use of face-masks, goggles, face-shields, gloves, and gowns, 
with a study conducted in Switzerland determining that the most effective coverage is offered by a 
combined use of all of these forms of PPE [10-12]. There are more stringent guidelines as to what forms 
of PPE offer the most protection: masks must be either N-95 or FFP2 grade material to block the small 
size of viral particles (70-90 nm) that standard surgical masks are ineffective at blocking; masks must also 
be well-fitted, ensuring complete coverage around the nose and mouth [10]. Furthermore, face-shields must 
extend below the chin and to the ears, while also allowing space for goggles and a mask to be worn 
underneath [11].  
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Among the primary concerns regarding the use of PPE is that healthcare workers have been experiencing 
a shortage of protective equipment, as well as a possible lack of adequate training regarding its use; this 
poses a significant risk to the health and lives of frontline workers [10, 11]. Some recommendations, such 
as the manufacture of face-shields and other forms of PPE within the hospital, have been made to increase 
the availability and distribution of PPE to healthcare workers [11]. A perspective of the SEIPS model 
developed in Singapore also suggests that the PPE worn be selected based on the viral load and risk of 
infection of certain procedures, as this would slow the depletion of supplies [9]. A study in the United 
Kingdom proposes that a supervisor or “buddy-system” be utilized when dressing in PPE to ensure proper 
placement and use [10]. In developing countries as well, such as Africa, a shortage of PPE has been noticed; 
increases in manufacture of these materials and other vital medical equipment has been progressing [13]. 
Due to the rough terrain and difficult-to-reach locations of some medical clinics and hospitals in Africa, 
there has been an operation of utilizing drones to transport material quickly and efficiently, greatly reducing 
the transport time of imperative medical supplies [13]. Without the use of PPE, the spread of the 
coronavirus would increase exponentially and put the lives of populations in potential danger, making the 
virus even more difficult to control. 
2.3 Treatment Options 
The symptoms of COVID-19 can be discomforting and debilitating, with the most common consisting of 
dry cough, fever, and shortness of breath, which may manifest into pneumonia and develop further 
complications that may lead to death [2, 14]. Furthermore, the symptoms experienced by children can be 
different than those experienced by adults and tends to take the form of another ailment: Pediatric 
Multisystem Inflammatory Syndrome, characterized by fever, cough, edema, and decreased heart 
functioning [15]. Due to the virus’s novelty, at the disease’s outset there was no vaccine or medication 
available to cure the illness; however, extensive and rapid several clinical trials have been conducted on 
individuals who suffer from COVID-19.  England has made many attempts to establish a proper treatment 
option for COVID-19; among these are the use of medications such as Chloroquine and 
Hydroxychloroquine [16, 17]. Chloroquine and Hydroxychloroquine have been utilized to treat a variety of 
conditions, such as malaria, arthritis, SARS, and MERS; they function by conducting a neutralization 
reaction that will deactivate acids [16, 17]. If a cell is equipped with chloroquine/hydroxychloroquine and 
becomes invaded by a virus, it will be able to neutralize the acidic environment required for the virus to 
survive [16]. Studies in England have also found Remdesivir to be a promising remedial approach against 
COVID-19, as it functions to inhibit the replication processes of viruses [16, 17]. 
One of the recent treatment methods explored in Europe has been the use of convalescent plasma, which 
is obtained from an individual who survived a virus and contains antibodies for fighting against the viral 
particles [18]. Convalescent plasma is normally utilized during epidemic situations, in which there is a lack 
of vaccination or effective cure for an illness, as seen during the Spanish influenza of 1918-1920 [18]. Studies 
administered in England and Wuhan, China found that when administered to an individual with COVID-
19, convalescent plasma works best in the early stages of viral infection, as the antibodies IgG and IgM are 
at their highest levels [18, 19]. Convalescent plasma also does not have any known adverse side-effects and 
allows for protection of further infection for up to a few months after injection [18, 19]. Besides, clinical 
trials conducted in China found that the use of convalescent plasma also assists in the functioning of the 
cardiovascular and immune systems, providing increased oxygenation to tissues, and decreases 
inflammation and viral load, with a lesser risk of being admitted to the Intensive Care Unit [18, 19]. While 
convalescent plasma has been quite effective in treating COVID-19, there has been an issue that is difficult 
to overcome: the supply of convalescent plasma to is too low to assist in treating every individual who is 
infected; this is because far more individuals are ill with the coronavirus than those who have fully recovered 
[18]. It is also imperative to ensure that the convalescent plasma is devoid of any other pathogens and 
impurities; the process of filtering plasma mirrors the screening process of blood transfusions: all 
contaminations must be removed via the use of Pathogen Reduction Technology (PRT) [18]. Countries 
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such as Australia and New Zealand, however, do not have access to such technologies, rendering the need 
for stringent donor guidelines [5]. 
The year 2021 has seen mass rollout of COVID-19 vaccine in several nations to serve a high proportion of 
the adult population, and currently approved vaccines have been significantly effective in countering 
disease’s severity and mortality rates; however, equitable vaccine access around the globe continues to be 
challenge [20]. Concerns about vaccination could be eliminated by strengthening awareness of COVID-19 
vaccine among health care workers (HCWs), especially female HCWs under 30 years with no history of 
influenza vaccination [21]. A recent analysis has reviewed the development of COVID-19 vaccines, 
underlining the efficacy and vaccination reactions of the authorised vaccines, as well as the mechanisms, 
storage, and dosage specification of vaccine candidates at the advanced stage of development while also 
considering potential challenges [22]. In a quantitative synthesis of phase III trials to detect modifying 
factors that might potentially influence the clinical efficacy of COVID-19 vaccines, network meta-analysis 
provided the following rank of effectiveness: BNT162b2 ≃ mRNA-1273 > Sputnik V >> AZD1222 [23]. 
In response to the overwhelming pace and volume of global vaccine research, an online, interactive vaccine 
tracker has been developed, hosted by the Vaccine Centre at the London School of Hygiene and Tropical 
Medicine, UK [24]. Clinical trials for COVID-19 vaccination had been underway since 2020 in many 
countries, including a few that conducted animal trials for effectiveness and one study expedited towards 
human trials [17]. The adenovirus vaccine, among others, has entailed the application of an inactivated form 
of the coronavirus and the use of plasmid DNA to fight the virus prior to infection [25]. Furthermore, 
results of this study have suggested a potential roadmap for designing universal vaccine(s) against the broad 
range of coronaviruses by continuing exploration of the B-cell repertoire to identify cross-reactive epitopes. 
Despite the development of diverse COVID-19 vaccines worldwide, owing to concerns around their 
relative safety and efficacy coupled with vaccination hesitancy among people, healthcare workers are 
advised to continue to utilize symptom management techniques combined with increased availability and 
affordability of testing services to care for patients, including asymptomatic carriers. 
2.4 Management of COVID-19 Symptoms 
According to the National Institute for Health and Care Excellence (NICE), treatment of the common 
symptoms of COVID-19 depends on the severity of the condition; for example, a light cough and sore 
throat may be alleviated with honey, while a more powerful cough may render the need of a codeine 
medication [14]. The administration of paracetamol has been found to be most effective in reducing fevers 
of those who are ill with COVID-19 [14]. In order to manage shortness of breath, certain breathing 
techniques have been effective, such as “pursed-lip breathing” as well as medications like antiemetics [14]. 
Furthermore, ventilators may be required if the patient has severe difficulty breathing on their own; 
however, there have been shortages of ventilators in major hospitals due to the large influx of COVID-19 
patients [26]. Thus, hospitals in Brazil have been proposing the use of anesthesia machines to substitute the 
use of ventilators whenever necessary [26].  
COVID-19 can also take a psychological toll, increasing levels of anxiety and stress among the patient, 
family, and healthcare professionals [14, 27]. In a study conducted in China, there were higher incidences 
of stress and anxiety by healthcare workers due to the COVID-19 pandemic, with nurses experiencing 
worse symptoms than physicians; this also coincides with the experiences of hospitals in Greece [27]. The 
stress experienced by the individual may also manifest into physical discomfort viz; difficulty in breathing, 
hypoxia, and constipation [14]. Among the most common corrective actions for anxiety and stress during 
the pandemic is communication; patients, families, and healthcare workers must address any concerns 
regarding prognosis and treatment [14, 27]. The administration of anti-anxiety medications, such as 
benzodiazepine may also be helpful in easing anxiety [14]. Adjusting to the new way of life the pandemic 
has brought along is challenging and may take some time to become accustomed to; however, through 
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interpersonal interactions regarding the virus and coping measures, people may be able to remain calm and 
make appropriate decisions regarding their health safety and management. 
3 Discussion 
COVID-19 has led to remarkable reforms in healthcare research and management at multiple levels 
worldwide. In the United States and other countries around the world, most non-essential healthcare 
activities were cancelled or postponed, and governments had to declare a shut-down of in-person related 
economic activities in attempts to curb the spread of the virus. Several medical facilities have moved their 
functions online via remote services, such as Zoom meetings on Zoom, Skype, or other digital platforms. 
Students, faculty, and college administrators had already been facing a multitude of barriers in STEM 
education, given its changing landscape in recent times [28, 29]. In this context, COVID-19 impacted not 
only healthcare research and management but education in healthcare and STEM (among most other 
academic sectors), necessitating evidence-based strategies for effective pedagogy and assessment of STEM 
courses conducted online because of the pandemic [30-38]. 
Though absence of in-person interactions have made people face inconveniences often during these 
unusual circumstances, conscious efforts to inhibit the transmission of the virus must continue to be 
exercised by everyone to ensure health and wellness of themselves and others. These can be achieved by 
increased exposure to knowledge about the virus: how it functions or spreads, and how surfaces can be 
properly disinfected; in other words, the population must increase their health literacy [39]. Health literacy 
involves gathering accurate information in order to apply it to make judicious, informed decisions regarding 
one’s health [39]. Administrative authorities of many countries have been taking steps to promote health 
literacy; however, those would not be successful without active cooperation of the general population to 
educate themselves and their families and children about the importance of proper hygiene, cleanliness, and 
regular sanitary habits. Given the COVID-19-based global socioeconomic crisis, knowledge of food safety 
and scientific research undertaken to meet the rising demands of food and nutrition, especially in developing 
countries, need to be acquired and disseminated [40-43].  
Greater efficiency of research and management among healthcare professionals is not possible without 
improving healthcare/science education in schools and colleges. In order to meet the aggravated COVID-
19-based demands of e-pedagogy, educators and academic administrators may consider suitable instances 
of empowering the youth with awareness and interest in science through modern online tools such as cost-
effective mobile applications with real-world relevance at middle/high school or college levels [44-47], 
fostering engagement and learning among healthcare science students by developing and implementing 
virtual classrooms [48], organizing and supporting digital leadership forums [49], employing new means of 
course assessment such as peer-video-blogs [50], and may need to restructure novel assessment strategies 
recently designed for research-based science courses [51-55].  
On the other hand, COVID-19 has caused heightened health safety concerns and stress among people, so 
much so, that individuals are worried to even enter a healthcare facility. Due to this, many hematology 
departments are experiencing lower yields of blood samples donated or available for transfusions [4, 56]. 
On account of this shortage, hospitals in Africa have been implementing Patient Blood Management (PBM) 
techniques to decrease the need for blood transfusions whenever possible, which consist of increasing 
erythropoiesis and reducing the risk of blood loss [56]. Hematology departments in Australia are addressing 
this issue through administration of supplements that enhance the functioning of erythrocytes, such as iron, 
vitamin B12, and folic acid [5]. There is hope that, with such continued endeavors, complemented by 
fostering health literacy among the masses, the pandemic will be brought under control and the health of 
global populations will flourish again.  
4 Conclusions 
The impacts that the COVID-19 pandemic has had on healthcare research and management have been 
intense and alarming. Healthcare professionals have been applying their knowledge of pre-existing diseases 
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and viruses to their immediate practice in the field of medicine, including major shifts to telecommunication 
in multiple relevant domains, and altering treatment protocols to inhibit transmission of the infection 
through respiratory droplets. Significant efforts have been made to protect essential or frontline healthcare 
workers, patients, and the surrounding population with the use of PPE, while assessing the risk of 
contamination with appropriate combinations of protective wear. COVID-19 has not only influenced 
individuals physically, but also socially, economically, emotionally, and psychologically, necessitating timely 
and widespread communication of healthcare research/management updates to help people avoid stress 
and uncertainty during the pandemic, and to provide the population and healthcare workers with accurate 
information concerning the virus. While the novel coronavirus presents ambiguities regarding proper 
remedial measures to prevent the infection, control the symptoms, and cure the disease, various clinical 
research investigations are being performed throughout the world to determine the quickest and most 
effective form of care, with minimal side-effects. Furthermore, the history of earlier pandemics may provide 
some optimism that the spread of the coronavirus will eventually be under control and the case-curves 
would flatten based on successful production and dissemination of vaccines through validated human 
clinical trials coupled with generation of herd immunity in populations, improved antiviral medications, and 
cutting-edge treatment procedures. This paper encapsulates recently published scientific literature citing 
critical developments in healthcare research and management practices in response to COVID-19. 
Numerous fresh endeavours have been continuing across the world including faster and more accurate 
diagnostic strategies to detect the infection, design of vaccines, and better antiviral drugs for prevention 
and potential cure, to name a few.  Therefore, a possible limitation of the present literature review could be 
its inability to provide an exhaustive list of all relevant reports on the impact of COVID-19 on global health 
research and management. Nonetheless, the study could serve as a foundation for pertinent future projects; 
for instance, improvements aimed at ensuring cost-effective, personalized healthcare among 
underprivileged and minority populations and people from socioeconomically challenged backgrounds or 
difficult geographical locations in developing countries, on a case-by-case basis. Moreover, additional 
healthcare management and research on COVID-19-associated illnesses and the impact on pediatric 
patients is necessary for a cohesive understanding of the novel coronavirus and its implications in patients 
of specific age-groups. 
5 Declarations 
5.1 Study Limitations 
Owing to the ongoing status of the pandemic, new studies from various countries are continuing to be 
published on the topic. Hence, this literature review is not exhaustive of all possible COVID-19-related 
implementations of health research and management practices yet accomplished around the world. 
Recommended further research could focus on age-appropriate clinical interventions, with possible 
emphasis on minorities or underprivileged communities in developing countries, while also taking into 
consideration better treatment strategies and healthcare policy solutions regarding conditions associated 
with COVID-19; for example, Pediatric Multisystem Inflammatory Syndrome.  
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